Table 2 Cancer incidence rate per 100,000 person-years by sub-cohort groupa
Cancer | Region | CR(Male/Female) | ASR(Male/Female) |
|---|---|---|---|
All | Exposed | 904.4/541.1 | 566.2/307.0 |
Control | 1093.4/560.4 | 545.2/281.2 | |
Control-1 | 1048.3/618.7 | 509.9/306.5 | |
Control-2 | 1132.8/518.7 | 567.9/264.0 | |
RI cancer | Exposed | 572.9/308.3 | 358.6/189.3 |
Control | 667.7/313.2 | 343.1/161.2 | |
Control-1 | 614.4/352.2 | 295.8/181.5 | |
Control-2 | 714.3/285.3 | 375.0/146.5 | |
Stomach ca. | Exposed | 229.2/104.4 | 140.7/49.5 |
Control | 218.7/109.0 | 104.0/51.1 | |
Control-1 | 191.4/130.3 | 96.0/58.8 | |
Control-2 | 242.5/93.7 | 110.3/44.5 | |
Liver ca. | Exposed | 151.4/22.2 | 97.6/9.5 |
Control | 149.4/43.3 | 75.6/17.7 | |
Control-1 | 129.5/32.5 | 64.9/13.3 | |
Control-2 | 166.8/51.5 | 85.6/21.1 | |
Lung ca. | Exposed | 151.4/34.1 | 90.9/13.2 |
Control | 256.7/59.5 | 105.9/22.5 | |
Control-1 | 251.7/69.0 | 107.1/26.6 | |
Control-2 | 261.1/52.6 | 104.7/19.9 | |
Thyroid ca. | Exposed | 22.6/75.3 | 15.9/60.7 |
Control | 15.9/48.5 | 11.4/33.0 | |
Control-1 | 26.8/61.0 | 16.3/43.1 | |
Control-2 | 6.4/39.5 | 8.2/26.4 | |
Breast ca. | Exposed | −/56.5 | −/44.7 |
Control | −/38.3 | −/29.7 | |
Control-1 | −/40.6 | −/30.3 | |
Control-2 | −/36.6 | −/29.0 |